| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00204-015-1625-3 |
| P698 | PubMed publication ID | 26542539 |
| P50 | author | Doris Marko | Q42314581 |
| P2093 | author name string | Anika Schroeter | |
| Melanie Esselen | |||
| Isabel Anna Maria Groh | |||
| Malte Gründken | |||
| Olga Rudakovski | |||
| P2860 | cites work | DNA topoisomerases: structure, function, and mechanism | Q22065417 |
| (-)-Epigallocatechin gallate, a major constituent of green tea, poisons human type II topoisomerases | Q24627296 | ||
| Bioflavonoids as poisons of human topoisomerase II alpha and II beta | Q24627367 | ||
| Dietary polyphenols as topoisomerase II poisons: B ring and C ring substituents determine the mechanism of enzyme-mediated DNA cleavage enhancement | Q24642324 | ||
| Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing | Q28140019 | ||
| The comet assay for DNA damage and repair: principles, applications, and limitations | Q28248760 | ||
| GammaH2AX and cancer | Q29614974 | ||
| Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity | Q33223479 | ||
| DNA lesions induced by replication stress trigger mitotic aberration and tetraploidy development | Q33526294 | ||
| Cell Cycle-Dependent Expression of Phosphorylated Histone H2AX: Reduced Expression in Unirradiated but not X-Irradiated G1-Phase Cells | Q34197636 | ||
| Safety assessment of allylalkoxybenzene derivatives used as flavouring substances - methyl eugenol and estragole | Q34686516 | ||
| Delphinidin modulates the DNA-damaging properties of topoisomerase II poisons | Q34934083 | ||
| H2AX: functional roles and potential applications | Q34982397 | ||
| Structure, molecular mechanisms, and evolutionary relationships in DNA topoisomerases | Q35771555 | ||
| PASSCLAIM--diet-related cancer | Q35819510 | ||
| Catalytic function of DNA topoisomerase II. | Q36422569 | ||
| Chemotherapy and dietary phytochemical agents | Q36516033 | ||
| The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells | Q37061217 | ||
| Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic: example: methyleugenol, CASRN: 93-15-2. | Q37683884 | ||
| gammaH2AX: a sensitive molecular marker of DNA damage and repair | Q37687078 | ||
| Molecular analysis of yeast and human type II topoisomerases. Enzyme-DNA and drug interactions. | Q38320285 | ||
| Plant polyphenols and oxidative metabolites of the herbal alkenylbenzene methyleugenol suppress histone deacetylase activity in human colon carcinoma cells. | Q39182792 | ||
| Gene expression profiling of systems involved in the metabolism and the disposition of xenobiotics: comparison between human intestinal biopsy samples and colon cell lines | Q39417799 | ||
| Genotoxicity of dietary, environmental and therapeutic topoisomerase II poisons is uniformly correlated to prolongation of enzyme DNA residence | Q39552708 | ||
| H2AX phosphorylation as a genotoxicity endpoint. | Q39821608 | ||
| Human cytochrome p450 enzymes of importance for the bioactivation of methyleugenol to the proximate carcinogen 1'-hydroxymethyleugenol. | Q40330162 | ||
| Methyleugenol genotoxicity in the Fischer 344 rat using the comet assay and pathway-focused gene expression profiling | Q42732541 | ||
| Investigation of the role of the 2',3'-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs | Q43540847 | ||
| Catalytic inhibition of human DNA topoisomerase II by interactions of grape cell culture polyphenols | Q46989902 | ||
| Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation. | Q48160611 | ||
| Genotoxic potential of methyleugenol and selected methyleugenol metabolites in cultured Chinese hamster V79 cells. | Q48190032 | ||
| Anthocyanin-rich extracts suppress the DNA-damaging effects of topoisomerase poisons in human colon cancer cells. | Q50547051 | ||
| Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomes. | Q51535143 | ||
| Physiologically based biokinetic model of bioactivation and detoxification of the alkenylbenzene methyleugenol in rat. | Q51662672 | ||
| Genotoxicity and endoreduplication inducing activity of the food flavouring eugenol. | Q51808791 | ||
| Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. | Q51834143 | ||
| P433 | issue | 11 | |
| P921 | main subject | methyl eugenol | Q419829 |
| P304 | page(s) | 2809-2823 | |
| P577 | publication date | 2015-11-05 | |
| P1433 | published in | Archives of Toxicology | Q635837 |
| P1476 | title | Methyleugenol and oxidative metabolites induce DNA damage and interact with human topoisomerases | |
| P478 | volume | 90 |
| Q38716590 | In vitro genotoxicity of carcinogenic asarone isomers. | cites work | P2860 |
Search more.